
From the U.S. Code Online via GPO Access
[wais.access.gpo.gov]
[Laws in effect as of January 23, 2000]
[Document not affected by Public Laws enacted between
  January 23, 2000 and December 4, 2001]
[CITE: 42USC285c-3]

 
                 TITLE 42--THE PUBLIC HEALTH AND WELFARE
 
                    CHAPTER 6A--PUBLIC HEALTH SERVICE
 
              SUBCHAPTER III--NATIONAL RESEARCH INSTITUTES
 
   Part C--Specific Provisions Respecting National Research Institutes
 
   subpart 3--national institute of diabetes and digestive and kidney 
                                diseases
 
Sec. 285c-3. Interagency coordinating committees


(a) Establishment and purpose

    For the purpose of--
        (1) better coordination of the research activities of all the 
    national research institutes relating to diabetes mellitus, 
    digestive diseases, and kidney, urologic, and hematologic diseases; 
    and
        (2) coordinating those aspects of all Federal health programs 
    and activities relating to such diseases to assure the adequacy and 
    technical soundness of such programs and activities and to provide 
    for the full communication and exchange of information necessary to 
    maintain adequate coordination of such programs and activities;

the Secretary shall establish a Diabetes Mellitus Interagency 
Coordinating Committee, a Digestive Diseases Interagency Coordinating 
Committee, and a Kidney, Urologic, and Hematologic Diseases Coordinating 
Committee (hereafter in this section individually referred to as a 
``Committee'').

(b) Membership; chairman; meetings

    Each Committee shall be composed of the Directors of each of the 
national research institutes and divisions involved in research with 
respect to the diseases for which the Committee is established, the 
Division Director of the Institute for the diseases for which the 
Committee is established, the Under Secretary for Health of the 
Department of Veterans Affairs, and the Assistant Secretary of Defense 
for Health Affairs (or the designees of such officers) and shall include 
representation from all other Federal departments and agencies whose 
programs involve health functions or responsibilities relevant to such 
diseases, as determined by the Secretary. Each Committee shall be 
chaired by the Director of NIH (or the designee of the Director). Each 
Committee shall meet at the call of the chairman, but not less often 
than four times a year.

(c) Annual report

    Each Committee shall prepare an annual report for--
        (1) the Secretary;
        (2) the Director of NIH; and
        (3) the Advisory Board established under section 285c-4 of this 
    title for the diseases for which the Committee was established,

detailing the work of the Committee in carrying out paragraphs (1) and 
(2) of subsection (a) of this section in the fiscal year for which the 
report was prepared. Such report shall be submitted not later than 120 
days after the end of each fiscal year.

(July 1, 1944, ch. 373, title IV, Sec. 429, as added Pub. L. 99-158, 
Sec. 2, Nov. 20, 1985, 99 Stat. 843; amended Pub. L. 100-527, 
Sec. 10(4), Oct. 25, 1988, 102 Stat. 2641; Pub. L. 102-405, title III, 
Sec. 302(e)(1), Oct. 9, 1992, 106 Stat. 1985.)


                               Amendments

    1992--Subsec. (b). Pub. L. 102-405 substituted ``Under Secretary for 
Health of the Department of Veterans Affairs'' for ``Chief Medical 
Director of the Department of Veterans Affairs''.
    1988--Subsec. (b). Pub. L. 100-527 substituted ``Chief Medical 
Director of the Department of Veterans Affairs'' for ``Chief Medical 
Director of the Veterans' Administration''.


                    Effective Date of 1988 Amendment

    Amendment by Pub. L. 100-527 effective Mar. 15, 1989, see section 
18(a) of Pub. L. 100-527, set out as a Department of Veterans Affairs 
Act note under section 301 of Title 38, Veterans' Benefits.
